Skip to main content

Advertisement

Table 4 Association of HAART and other variables with renal function paramaters

From: HAART, DOTS and renal disease of patients co-infected with HIV/AIDS and TB in the South West Region of Cameroon

  eGFR P-value Serum creatinine P-value Serum albumin P-value Serum total protein P-value
HAART 6.9 (0.79–59.5) 0.080 2.5 (0.94–6.43) 0.064 12.8 (2.74–59.57) 0.001 2.0 (0.92–4.37) 0.079
Adjusted for HAART + HAART/DOTS 4.6 (0.49–42.2) 0.181 2.6 (0.97–6.72) 0.058 0.58 (0.5-6–71) 0.664 2.1 (0.97–4.71) 0.060
Adjusted for HAART + HAART/DOTS + Age (>40 years) 3.5 (1.1–11.3) 0.036 1.1 (0.52–2.40) 0.775 0.36 (0.11–1.24) 0.107 1.7 (0.88–3.22) 0.113
Adjusted for HAART + HAART/DOTS + Age (>40 years) + Gender (female) 6.0 (1.41–25.61) 0.015 0.7 (0.35–1.63) 0.488 0.95 (0.34–2.67) 0.931 1.4 (0.75–2.74) 0.270
Adjusted for HAART + HAART/DOTS + Age (>40 years) + Gender (female) + BMI (≥25 kg/m2) 4.8 (1.48–15.35) 0.009 2.2 (1.0–4.85) 0.050 1.01 (0.31–3.27) 0.982 0.7 (0.35–1.59) 0.449
Adjusted for HAART + HAART/DOTS + Age (>40 years) + Gender (female) + BMI (≥25 kg/m2) + Hypertension 3.9 (0.56–26.63) 0.170 11.9 (3.32–42.54) <0.001 1.42 (0.14–14.53) 0.770 6.0 (1.77–19.98) 0.004
  1. Key: BMI body mass index, DOTS Direct Observed Therapy, Short-course, HAART Highly Active Antiretroviral Therapy, Reference group participants on DOTS